Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Short stature-deafness-neutrophil dysfunction-dysmorphism syndrome is characterized by short stature, sensorineural deafness, mutism, facial dysmorphism and abnormal neutrophil chemotaxis (leading to recurrent infections).
Features include common findings: Inner ear hearing loss (sensorineural hearing impairment), Glaucoma, Craniosynostosis, and Mutism and others; and sometimes findings: Neoplasm.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
Biomarker and diagnostic research for short stature-deafness-neutrophil dysfunction-dysmorphism syndrome has been reported in the published literature.
Phenotype severity distribution: 7 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for short stature-deafness-neutrophil dysfunction-dysmorphism syndrome.
297 publications have been identified in PubMed for short stature-deafness-neutrophil dysfunction-dysmorphism syndrome. Kisho has analyzed 171 by research type. Research spans Review / Meta-Analysis (44%), Case Report / Case Series (19%), and Basic Science / Preclinical (12%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 76 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 1:14 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
1 |
Glaucoma |
Head and neck | 1 | Craniosynostosis |
Brain and nerves | 1 | Mutism |
Neoplasm | 1 | Neoplasm |
Growth and development | 1 | Short stature |
Patient case studies | 32 | 19% |
Laboratory research | 20 | 12% |
Disease patterns and progression | 19 | 11% |
Clinical study results | 14 | 8% |
Testing and diagnosis research | 8 | 5% |
Other research | 1 | 1% |
New treatment approaches | 1 | 1% |
Xie T (2026). [PMID: 41308837](https://pubmed.ncbi.nlm.nih.gov/41308837/). *Ageing Res Rev*. [Review / Meta-Analysis]
Mula P (2026). [PMID: 41534401](https://pubmed.ncbi.nlm.nih.gov/41534401/). *Med Clin (Barc)*. [Review / Meta-Analysis]
Quelhas D (2026). [PMID: 41554664](https://pubmed.ncbi.nlm.nih.gov/41554664/). *Journal of inherited metabolic disease*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Arcuri L (2026). [PMID: 41979702](https://pubmed.ncbi.nlm.nih.gov/41979702/). *Curr Hematol Malig Rep*. [Review / Meta-Analysis]
Jeong H (2026). [PMID: 41519378](https://pubmed.ncbi.nlm.nih.gov/41519378/). *Ophthalmology. Retina*. [Basic Science / Preclinical]
Vanhanen J (2026). [PMID: 40562592](https://pubmed.ncbi.nlm.nih.gov/40562592/). *Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology*. [Basic Science / Preclinical]
Chen Y (2026). [PMID: 42255433](https://pubmed.ncbi.nlm.nih.gov/42255433/). *Front Endocrinol (Lausanne)*. [Review / Meta-Analysis]
Girish V (2026). [PMID: 29763077](https://pubmed.ncbi.nlm.nih.gov/29763077/). *Unknown Journal*. [Epidemiology / Natural History]
Silberman EK (2026). [PMID: 41324787](https://pubmed.ncbi.nlm.nih.gov/41324787/). *Drugs*. [Review / Meta-Analysis]